Holen Sie sich die Stockscreener-App
8.155
2.72%
-0.228
Handel nachbörslich:
8.26
0.105
+1.29%
Schlusskurs vom Vortag:
$8.383
Offen:
$8.37
24-Stunden-Volumen:
9,684
Relative Volume:
0.06
Marktkapitalisierung:
$18.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-14.70%
1M Leistung:
-5.61%
6M Leistung:
+7.29%
1J Leistung:
-65.19%
1-Tages-Spanne:
$8.10
$8.37
1-Wochen-Bereich:
$8.0101
$9.61
52-Wochen-Spanne:
$6.05
$24.04
Metavia Inc Stock (MTVA) Company Profile
Firmenname
Metavia Inc
Sektor
Branche
Telefon
(857) 702-9600
Adresse
545 CONCORD AVENUE, CAMBRIDGE
Vergleichen Sie MTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
8.155 | 19.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
Metavia Inc Aktie (MTVA) Neueste Nachrichten
What risks investors should watch in MetaVia Inc. stock2025 Price Targets & Entry and Exit Point Strategies - ulpravda.ru
Research Analysts Issue Forecasts for MetaVia Q4 Earnings - Defense World
VIX Spike: Why retail investors favor MetaVia Inc stock2025 Winners & Losers & Low Risk High Reward Ideas - moha.gov.vn
Will MetaVia Inc. stock maintain growth storyDurability and Wear Notes & HOKA model picks for your routine - ulpravda.ru
FY2030 Earnings Forecast for MetaVia Issued By HC Wainwright - Defense World
What momentum indicators show for MetaVia Inc. stockMarket Sentiment Review & Stepwise Trade Signal Implementation - ulpravda.ru
Why retail investors favor MetaVia Inc. stockPortfolio Return Summary & Community Verified Watchlist Alerts - ulpravda.ru
Can MetaVia Inc. stock rebound after recent weaknessJuly 2025 Breakouts & Community Driven Trade Alerts - ulpravda.ru
Aug Movers: Can MetaVia Inc stock rebound after recent weaknessQuarterly Performance Summary & AI Powered Market Entry Strategies - moha.gov.vn
Will MetaVia Inc. stock reach all time highs in 2025July 2025 Trends & Free High Return Stock Watch Alerts - ulpravda.ru
How MetaVia Inc. stock benefits from global expansion2025 Market WrapUp & Weekly High Conviction Trade Ideas - ulpravda.ru
MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial - Indian Pharma Post
HC Wainwright Issues Positive Forecast for MetaVia (NASDAQ:MTVA) Stock Price - Defense World
MetaVia reports encouraging phase 1 DA-1726 obesity data - MSN
MTVA Stock: HC Wainwright & Co. Raises Price Target to $40.00 | - GuruFocus
MetaVia : Presentation January 2026 - marketscreener.com
MetaVia Inc. reports preliminary year-end cash balance and no debt - Investing.com Nigeria
MetaVia Inc. reports preliminary year-end cash balance and no debt By Investing.com - Investing.com South Africa
MetaVia reports results from Phase 1b trial of DA-1726 - TipRanks
MetaVia reports significant results from obesity drug trial - Investing.com India
MetaVia reports significant results from obesity drug trial By Investing.com - Investing.com Australia
MetaVia Reports Encouraging Phase 1 DA-1726 Obesity Data - TipRanks
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic DiseaseDemonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile - PR Newswire
MetaVia (NASDAQ:MTVA) Stock Rating Upgraded by Wall Street Zen - Defense World
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference - PR Newswire
Big Money Moves: Can MetaVia Inc stock rebound after recent weaknessTrend Reversal & Weekly Watchlist for Hot Stocks - moha.gov.vn
IMG, MTVA, USREF, TGL: These four stocks trade ex-reverse split on Friday - MSN
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement - Sahm
MetaVia regains compliance with Nasdaq minimum bid price requirement By Investing.com - Investing.com Australia
Metavia regains compliance with Nasdaq minimum bid price requirement - marketscreener.com
MetaVia regains compliance with Nasdaq minimum bid price requirement - Investing.com
Gains Report: Can MetaVia Inc stock deliver sustainable ROEJuly 2025 Pullbacks & Low Risk Entry Point Guides - moha.gov.vn
What margin trends mean for MetaVia Inc. stock2025 Market Overview & Weekly High Return Stock Forecasts - Улправда
How analysts rate MetaVia Inc. stock today2025 EndofYear Setup & High Accuracy Investment Signals - ulpravda.ru
MetaVia Regains Nasdaq Compliance After Bid Price Recovery - The Globe and Mail
Why MetaVia Inc. stock is in analyst buy zoneJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - Улправда
MetaVia regains Nasdaq compliance after bid price recovery - MSN
Is MetaVia Inc. stock recession proofJuly 2025 Rallies & Risk Controlled Stock Alerts - Улправда
MTVA: New Data for Vanoglipel (DA-1241) Presented at AASLD - Smartkarma
MetaVia Inc trading resumes - MSN
MetaVia Inc trading halted, volatility trading pause - MSN
MetaVia Inc. trading halted, news pending - MSN
MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD… - Zacks Small Cap Research
MTVA: New Data for Vanoglipel (DA-1241) Presented at AASLD… - Yahoo Finance
Finanzdaten der Metavia Inc-Aktie (MTVA)
Es liegen keine Finanzdaten für Metavia Inc (MTVA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Metavia Inc-Aktie (MTVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):